Defining Best Practice in Early and Managed Access Programmes for the Global Pharmaceutical Industry

Pharma, biotech and life sciences companies are under increasing pressure from patients and physicians alike to provide early access programmes (EAPs) to orphan and investigational drugs. As a result the need to understand the challenges associated with these complex programmes and develop a roadmap for succesful planning and execution of EAPs increases with it.

The Early Access Programmes Summit - the world's first and most prestigious EAP event - returns in November 2016, where the leading figures in early and managed access programmes will be tackling the challenges at the very heart of the issues within this complex field.

Download Agenda

Key Challenges and Topics of Debate Include:

Experience 3 Days of Expertly Curated Content

Anticipating demand and make the decision on whether to run an EAP: risk vs benefit, safety data, resources and stakeholder engagement

Meet With and Compare Dozens of Leading-Edge Solution Providers

Navigating the minefield of country-specific regulatory requirements on a global scale

Forge New Connections and Benchmark Against Peers

Developing an effective planning strategy to forecast and establish accurate drug supply

New This Year! IT Modernization Track

Ensuring equitable drug supply allocation

New This Year! ITFM Boot Camp

Successfully implementing, monitoring and closing out an EAP

Take Advantage of Our Group Discounts and Bring the Whole Team

Understanding the patient perspective and utilising independent bodies to facilitate and support EAPs

Register your place at the world's foremost managed access event, taking place in London this November! The two days of industry leading insight will include case studies from leading pharmaceutical companies including Pfizer, Shire, Johnson and Johnson, Sanofi and many more, who are making significant steps on the road to overcome these challenges, implementing and executing successful EAPs and MAPs around the world.

Why not take a look at our resource centre? You can download interviews with Jose Ricardo Perez, Novartis Oncology, and Kennith Moch, Former CEO at Chimerix.

Download Agenda

2016 Speakers Include:

View All Speakers

What is the industry saying about Pharma IQ's events?


Sponsors & Exhibitors
Media Partners